More than 8 million Americans are currently living with psoriasis, a topical condition that causes itchy and dry patches to develop on the skin. A recent study on the skin condition has found that the level of vitamin D may play a role in the severity of psoriasis. The study involved close to 500 cases of psoriasis from the National Health Nutrition Examination Survey (NHANES) and is among the largest studies on psoriasis.
Study results revealed that an individual’s levels of vitamin D may determine how far their psoriasis advances, with increasingly severe psoriasis occurring alongside decreasing vitamin D levels in the blood. Because most psoriasis treatments involve applying topical medication, the study could open up a new frontier in psoriasis treatment that involves taking oral vitamin D supplements or subsisting on a vitamin D-rich diet.
Warren Alpert Medical School of Brown University Department of Dermatology associate professor Eunyoung Cho, ScD, led the research team looking into the connection between diet, environmental factors and inflammatory topical conditions such as psoriasis. The research team posits that vitamin D may affect psoriasis severity via attacks on the cells that aid in repairing the skin and affecting the natural immune response.
Cho explained that as the public becomes increasingly interested in vitamin supplements, the research team wanted to investigate the effect vitamin D levels could have on psoriasis severity. She and her team looked through more than 40,000 participants in the National Health and Nutrition Examination Survey before identifying 491 cases of psoriasis. They also took data on vitamin D levels, gender, age, race, smoking status, body mass index and body surfaces affected by psoriasis.
After adjusting the data set for factors such as smoking that could affect the result, they found that low vitamin D levels were significantly associated with developing more severe psoriasis. Furthermore, patients with the highest vitamin D levels had the lowest affected body areas while individuals with the lowest levels of vitamin D were most affected by psoriasis in terms of body surface area.
According to Warren Alpert Medical School of Brown University MD candidate Rachel K. Lim, this is the second study ever to compare the relationship between psoriasis and vitamin D using data from NHANES.
By including recent data in the dataset, Lim explains, the research team analyzed three times more psoriasis cases and delivered more statistically relevant and up-to-date data.
Kim presented the study’s findings at the annual American Society for Nutrition meeting last week.
With many firms such as Jupiter Wellness Inc. (NASDAQ: JUPW) bringing to market products intended to help in the management of psoriasis, the realization that vitamin D is vital could provide an added tool to keep this condition manageable.
NOTE TO INVESTORS: The latest news and updates relating to Jupiter Wellness Inc. (NASDAQ: JUPW) are available in the company’s newsroom at https://ibn.fm/JUPW
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
David Eby, the Premier of British Columbia, has revealed that a wide range of American healthcare workers,…
Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…
High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…
Most existing cancer treatments not only attack cancer cells but also adversely impact healthy body cells. The…
LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…
Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent…